Menu

Parts of U.S. Saw an Increase in Zika-Linked Birth Defects in 2016

The rise occurred in areas with confirmed local transmission, according to a new CDC report. 

Jan 26, 2018
Katarina Zimmer

ISTOCK, NECKAEV-KON In the latter half of 2016, US jurisdictions with known local transmission of Zika saw a 21 percent increase in birth defects potentially linked to the virus, according to a report published today (January 26) by the Centers for Disease Control and Prevention (CDC).

“This finding underscores the importance of surveillance for birth defects potentially related to Zika virus infection and the need for continued monitoring in areas at risk for Zika transmission and exposure,” the authors write in the report.

The CDC team searched for cases of Zika-associated birth defects, such as microcephaly, in just under one million births that occured across 15 US states and territories in 2016. These included areas with documented cases of local Zika transmission (Puerto Rico, southern Florida, and a portion of southern Texas) and locations with confirmed instances of travel-associated Zika infections.

The researchers found that three of every 1,000 babies born in those areas had a birth defect that could have been linked to Zika infection in their mothers. When they specifically focused on areas with local transmission and excluded birth defects with weaker links to Zika, such as neural tube defects and other early brain malformations, they found a statistically significant increase in the number of Zika-linked birth defects in the second half of 2016 compared to the first.  

The study authors expect another potential increase of Zika-related birth defects in 2017, given that the peak of confirmed local transmission occurred in the second half of 2016.

Brenda Fitzgerald, director of the CDC, and her colleagues argue that these numbers might only represent a fraction of the full effect of congenital Zika virus infections. “[S]ome healthy infants born following pregnancies complicated by Zika may have developmental problems that become evident later,” they write in a JAMA commentary. “[O]ngoing surveillance is needed to determine the extent to which congenitally exposed infants without apparent birth defects will experience similar or other developmental issues.”

The number of laboratory-confirmed Zika cases has declined since 2016, according to CDC data. Some scientists believe that this is because much of the population in the Americas developed immunity to the virus, Science reported last year.

Nevertheless, there are ongoing efforts to develop Zika vaccines to prevent future epidemics and to control populations of Zika-carrying mosquito species. 

See “Zika Vaccine Shows Promise in Early Clinical Trial

CENTERS FOR DISEASE CONTROL AND PREVENTION

 

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!